// App-Quantinova.ai

BSH2020‐PO‐104 : IGHV analysis utilising the Ion GeneStudio™ S5 System and the Oncomine™ BCR IGH‐LR assay – early access experience

Researchers

Presenter

  • Z. Davis

Principal Investigators

  • N/A

Medical Centers

  • Dept of Molecular Pathology,Royal Bournemouth Hospital,Bournemouth,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Immunoglobulin heavy-chain variable region gene

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved